Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
Abstract Type 2 innate lymphoid cells (ILC2) potentiate immune responses, however, their role in mediating adaptive immunity in cancer has not been assessed. Here, we report that mice genetically lacking ILC2s have significantly increased tumour growth rates and conspicuously higher frequency of cir...
Guardado en:
Autores principales: | Iryna Saranchova, Jeffrey Han, Rysa Zaman, Hitesh Arora, Hui Huang, Franz Fenninger, Kyung Bok Choi, Lonna Munro, Cheryl G. Pfeifer, Ian Welch, Fumio Takei, Wilfred A. Jefferies |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e05d74787a9a40e3a597db224e017b20 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum free culture for the expansion and study of type 2 innate lymphoid cells
por: Pablo de Lucía Finkel, et al.
Publicado: (2021) -
Actuators
Publicado: (2013) -
Sensors and actuators.
Publicado: (1990) -
Sensors and actuators.
Publicado: (1990) -
Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability
por: Zhengjun Gao, et al.
Publicado: (2017)